← All stocks

ASSEMBLY BIOSCIENCES, INC.

ASMB Net selling
CIK 0001426800 #2862 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$14.69K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$14.69K
5 of 5 sales
Net
−$14.69K
−$14.69K against sales at will

By person

9 insiders · 5 transactions
4.0×

Jason A. Okazaki holds only 4.0 times base salary in stock. $2.60M of shares against $647.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason A. Okazaki last reported holding, valued at $23.25, the price Common Stock was last bought or sold at on the open market here, on 17 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bjorkquist Jeanette M
PFO and PAO
$9.43K (3)
−$9.43K
14,560
$338.52K
+363.4%
White Nicole S
Chief Manufacturing Officer
$5.26K (2)
−$5.26K
37,477
$871.34K
GILEAD SCIENCES, INC. entity
10% owner
4,977,089
$115.72M
+292.2%
Schornstein Alexander
10% owner
728,113
$16.93M
+5.0%
Okazaki Jason A
CEO and President
111,916
$2.60M
Delaney William E IV
Chief Scientific Officer
45,642
$1.06M
+709.0%
Gaggar Anuj
Chief Medical Officer
28,000
$651.00K
McHutchison John G
Director
18,347
$426.57K
−4.0%
Houghton Michael
Director
3,202
$74.45K

No percentages here. This company's share count has moved by a factor of 3.2 over the window, from 6,356,286 to 20,360,596 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 746,698
History held since 31 Mar 2017